Biologist discusses promise of disease-specific stem cells

08/27/2008 | MIT Technology Review

The creation of disease-specific stem cells will advance research into degenerative disorders and allow scientists to examine how environmental factors influence illnesses, said Doug Melton, co-director of the Harvard Stem Cell Institute. The institute intends to distribute the cell lines to other scientists worldwide to encourage "basic research" on embryonic stem cells, Melton said.

View Full Article in:

MIT Technology Review

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT